Literature DB >> 30633907

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.

Moshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, John P Ray, Carl G de Boer, Russell W Jenkins, David J Lieb, Jonathan H Chen, Dennie T Frederick, Michal Barzily-Rokni, Samuel S Freeman, Alexandre Reuben, Paul J Hoover, Alexandra-Chloé Villani, Elena Ivanova, Andrew Portell, Patrick H Lizotte, Amir R Aref, Jean-Pierre Eliane, Marc R Hammond, Hans Vitzthum, Shauna M Blackmon, Bo Li, Vancheswaran Gopalakrishnan, Sangeetha M Reddy, Zachary A Cooper, Cloud P Paweletz, David A Barbie, Anat Stemmer-Rachamimov, Keith T Flaherty, Jennifer A Wargo, Genevieve M Boland, Ryan J Sullivan, Gad Getz, Nir Hacohen.   

Abstract

Entities:  

Year:  2019        PMID： 30633907      PMCID： PMC6647017          DOI： 10.1016/j.cell.2018.12.034

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  60 in total

Review 1.  Helper T cell differentiation.

Authors:  Jordy Saravia; Nicole M Chapman; Hongbo Chi
Journal:  Cell Mol Immunol       Date:  2019-03-12       Impact factor: 11.530

Review 2.  VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity.

Authors:  Mohamed A ElTanbouly; Walburga Croteau; Randolph J Noelle; J Louise Lines
Journal:  Semin Immunol       Date:  2019-04       Impact factor: 11.130

3.  IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors.

Authors:  Lauren Giuffrida; Kevin Sek; Melissa A Henderson; Imran G House; Junyun Lai; Amanda X Y Chen; Kirsten L Todd; Emma V Petley; Sherly Mardiana; Izabela Todorovski; Emily Gruber; Madison J Kelly; Benjamin J Solomon; Stephin J Vervoort; Ricky W Johnstone; Ian A Parish; Paul J Neeson; Lev M Kats; Phillip K Darcy; Paul A Beavis
Journal:  Mol Ther       Date:  2020-07-21       Impact factor: 11.454

Review 4.  Prognostic Biomarkers for Melanoma Immunotherapy.

Authors:  Christopher G Twitty; Laura A Huppert; Adil I Daud
Journal:  Curr Oncol Rep       Date:  2020-02-11       Impact factor: 5.075

Review 5.  Organized immune cell interactions within tumors sustain a productive T-cell response.

Authors:  Maria A Cardenas; Nataliya Prokhnevska; Haydn T Kissick
Journal:  Int Immunol       Date:  2021-01-01       Impact factor: 4.823

6.  Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy.

Authors:  Robert M Samstein; Chirag Krishna; Xiaoxiao Ma; Xin Pei; Ken-Wing Lee; Vladimir Makarov; Fengshen Kuo; Jonathan Chung; Raghvendra M Srivastava; Tanaya A Purohit; Douglas R Hoen; Rajarsi Mandal; Jeremy Setton; Wei Wu; Rachna Shah; Besnik Qeriqi; Qing Chang; Sviatoslav Kendall; Lior Braunstein; Britta Weigelt; Pedro Blecua Carrillo Albornoz; Luc G T Morris; Diana L Mandelker; Jorge S Reis-Filho; Elisa de Stanchina; Simon N Powell; Timothy A Chan; Nadeem Riaz
Journal:  Nat Cancer       Date:  2020-11-16

7.  Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis.

Authors:  N N Alrabadi; H M Abushukair; O E Ababneh; S S Syaj; S S Al-Horani; A A Qarqash; O A Darabseh; M M Al-Sous; S R Al-Aomar; Y B Ahmed; R Haddad; F A Al Qarqaz
Journal:  Clin Transl Oncol       Date:  2021-04-20       Impact factor: 3.405

8.  Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer.

Authors:  Sri Krishna; Frank J Lowery; Amy R Copeland; Erol Bahadiroglu; Ratnadeep Mukherjee; Li Jia; James T Anibal; Abraham Sachs; Serifat O Adebola; Devikala Gurusamy; Zhiya Yu; Victoria Hill; Jared J Gartner; Yong F Li; Maria Parkhurst; Biman Paria; Pia Kvistborg; Michael C Kelly; Stephanie L Goff; Grégoire Altan-Bonnet; Paul F Robbins; Steven A Rosenberg
Journal:  Science       Date:  2020-12-11       Impact factor: 47.728

9.  Rapid Serial Immunoprofiling of the Tumor Immune Microenvironment by Fine Needle Sampling.

Authors:  Juhyun Oh; Jonathan C T Carlson; Christian Landeros; Hakho Lee; Scott Ferguson; William C Faquin; John R Clark; Mikael J Pittet; Sara I Pai; Ralph Weissleder
Journal:  Clin Cancer Res       Date:  2021-07-07       Impact factor: 12.531

10.  The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis.

Authors:  Xin Hong; Whijae Roh; Ryan J Sullivan; Keith H K Wong; Ben S Wittner; Hongshan Guo; Taronish D Dubash; Moshe Sade-Feldman; Benjamin Wesley; Elad Horwitz; Genevieve M Boland; Dieuwke L Marvin; Todd Bonesteel; Chenyue Lu; François Aguet; Risa Burr; Samuel S Freeman; Laxmi Parida; Katherine Calhoun; Michelle K Jewett; Linda T Nieman; Nir Hacohen; Anders M Näär; David T Ting; Mehmet Toner; Shannon L Stott; Gad Getz; Shyamala Maheswaran; Daniel A Haber
Journal:  Cancer Discov       Date:  2020-11-17       Impact factor: 39.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.